BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37854229)

  • 1. Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly.
    Yan Z; Zeng M; Chen X; Yin Y; Liu Y
    Am J Transl Res; 2023; 15(9):5653-5663. PubMed ID: 37854229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
    Yamasaki S; Nitta H; Kondo E; Uchida N; Miyazaki T; Ishiyama K; Kiyota M; Matsuoka H; Ichinohe T; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
    Ann Hematol; 2019 Sep; 98(9):2213-2220. PubMed ID: 31327025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Jain P; Aoki E; Keating M; Wierda WG; O'Brien S; Gonzalez GN; Ferrajoli A; Jain N; Thompson PA; Jabbour E; Kanagal-Shamanna R; Pierce S; Alousi A; Hosing C; Khouri I; Estrov Z; Cortes J; Kantarjian H; Ravandi F; Kadia TM
    Ann Oncol; 2017 Jul; 28(7):1554-1559. PubMed ID: 28379307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for B-cell prolymphocytic leukemia in partial remission.
    Arima H; Ono Y; Tabata S; Matsushita A; Hashimoto H; Ishikawa T; Takahashi T
    Int J Hematol; 2014 Apr; 99(4):519-22. PubMed ID: 24470149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of hairy cell leukemia: the rare indolent hematological malignancy.
    Huang H; Liu Y; Zeng M; Chen X; Yin Y; Guo H; Yan Z; Lin J
    Am J Transl Res; 2024; 16(2):466-476. PubMed ID: 38463575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
    Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
    Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics And Outcome Of Biphenotypic Acute Leukemia: 10 Case Reports And Literature Review.
    Yu J; Li Y; Xing H; Pan Y; Sun H; Wan D; Liu Y; Xie X; Wang C; Sun L; Sun K; Jiang Z
    Cancer Manag Res; 2019; 11():9297-9306. PubMed ID: 31802948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
    Shvidel L; Shtalrid M; Bassous L; Klepfish A; Vorst E; Berrebi A
    Leuk Lymphoma; 1999 Mar; 33(1-2):169-79. PubMed ID: 10194135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
    Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
    Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
    Dearden CE; Matutes E; Cazin B; Tjønnfjord GE; Parreira A; Nomdedeu B; Leoni P; Clark FJ; Radia D; Rassam SM; Roques T; Ketterer N; Brito-Babapulle V; Dyer MJ; Catovsky D
    Blood; 2001 Sep; 98(6):1721-6. PubMed ID: 11535503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B and T cell prolymphocytic leukaemia.
    Cross M; Dearden C
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.
    Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W
    Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
    Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
    Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
    Murthy HS; Ahn KW; Estrada-Merly N; Alkhateeb HB; Bal S; Kharfan-Dabaja MA; Dholaria B; Foss F; Gowda L; Jagadeesh D; Sauter C; Abid MB; Aljurf M; Awan FT; Bacher U; Badawy SM; Battiwalla M; Bredeson C; Cerny J; Chhabra S; Deol A; Diaz MA; Farhadfar N; Freytes C; Gajewski J; Gandhi MJ; Ganguly S; Grunwald MR; Halter J; Hashmi S; Hildebrandt GC; Inamoto Y; Jimenez-Jimenez AM; Kalaycio M; Kamble R; Krem MM; Lazarus HM; Lazaryan A; Maakaron J; Munshi PN; Munker R; Nazha A; Nishihori T; Oluwole OO; Ortí G; Pan DC; Patel SS; Pawarode A; Rizzieri D; Saba NS; Savani B; Seo S; Ustun C; van der Poel M; Verdonck LF; Wagner JL; Wirk B; Oran B; Nakamura R; Scott B; Saber W
    Transplant Cell Ther; 2022 Apr; 28(4):187.e1-187.e10. PubMed ID: 35081472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation].
    Chen X; Liu ZY; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; He Y; Wei JL; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):542-549. PubMed ID: 36709130
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
    Shumilov E; Hasenkamp J; Szuszies CJ; Koch R; Wulf GG
    Acta Haematol; 2021; 144(1):105-110. PubMed ID: 32259827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment options in prolymphocytic leukemia.
    Robak T; Robak P
    Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].
    Wang Z; Xu MZ; Chen YF; Xue F; Zhang L; Hu YM; Li CW; Li SZ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1008-1014. PubMed ID: 32023731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.